Journal
EMBO MOLECULAR MEDICINE
Volume 6, Issue 1, Pages 80-98Publisher
WILEY
DOI: 10.1002/emmm.201302666
Keywords
UV; Src; PPAR beta/delta; keratinocyte; Skin cancer
Categories
Funding
- Swiss National Science Foundation
- Bonizzi-Theler-Stiftung
- Roche Foundation
- Swiss Cancer League
- Fondation pour la Recherche Medicale
- EU
- Etat de Vaud
- Lee Kong Chian School of Medicine
Ask authors/readers for more resources
Although non-melanoma skin cancer (NMSC) is the most common human cancer and its incidence continues to rise worldwide, the mechanisms underlying its development remain incompletely understood. Here, we unveil a cascade of events involving peroxisome proliferator-activated receptor (PPAR) beta/delta and the oncogeneSrc, which promotes the development of ultraviolet (UV)-induced skin cancer in mice. UV-induced PPAR beta/delta activity, which directly stimulatedSrcexpression, increased Src kinase activity and enhanced the EGFR/Erk1/2 signalling pathway, resulting in increased epithelial-to-mesenchymal transition (EMT) marker expression. Consistent with these observations, PPAR beta/delta-null mice developed fewer and smaller skin tumours, and a PPAR beta/delta antagonist prevented UV-dependentSrc stimulation. Furthermore, the expression ofPPAR beta/delta positively correlated with the expression ofSRCand EMT markers in human skin squamous cell carcinoma (SCC), and critically, linear models applied to several human epithelial cancers revealed an interaction between PPAR beta/delta and SRC and TGF beta 1 transcriptional levels. Taken together, these observations motivate the future evaluation of PPAR beta/delta modulators to attenuate the development of several epithelial cancers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available